When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Here’s how to pay the lowest prices for your prescription ...

   www.aol.com/finance/pay-lowest-prices...

   So, the savings you get with a card one month at a particular pharmacy may be lower, or nonexistent, when it’s time for a refill. “The best deal today may not be the best deal next month ...

3. Spironolactone - Wikipedia

   en.wikipedia.org/wiki/Spironolactone

   Spironolactone; Clinical data; Pronunciation / ˌ s p aɪ r oʊ n oʊ ˈ l æ k t oʊ n / SPY-roh-noh-LAK-tone, [1] / ˌ s p ɪər oʊ n oʊ ˈ l æ k t oʊ n / SPEER-oh-noh-LAK-tone [2] Trade names: Aldactone, others

4. Co-pay card - Wikipedia

   en.wikipedia.org/wiki/Co-pay_card

   An example: A brand offers a co-pay card giving patients the opportunity to save up to $20 off each prescription fill. A patient receives the co-pay card and visits their pharmacy. The patient provides his/her insurance card and co-pay card to the pharmacist. The pharmacist enters information into his/her pharmacy management system from both cards.

5. Mineralocorticoid receptor antagonist - Wikipedia

   en.wikipedia.org/wiki/Mineralocorticoid_receptor...

   However, spironolactone is metabolized to three active metabolites, which give it prolonged activity (13.8 – 16. 5 hours). Spironolactone has a long half-life and is excreted 47-51% through kidneys. Patients with chronic kidney disease therefore require close monitoring when taking the drug. Spironolactone is also eliminated through feces (35-41%

6. Get help paying for your prescription medications - AOL

   www.aol.com/2008/01/03/get-help-paying-for-your...

   If you're having trouble with the high costs at the pharmacy and you're being forced to choose between putting a meat loaf on the table or following doctor's orders, then you need to know that ...

7. RALES (trial) - Wikipedia

   en.wikipedia.org/wiki/RALES_(trial)

   The trial was stopped early because the beneficial effect of spironolactone on all-cause death exceeded the prespecified discontinuation requirements. Spironolactone reduced the risk of death by 30% compared to placebo. Additionally, there was a 35% reduction in the risk of hospitalization for worsening heart failure in the spironolactone group.